valsartan has been researched along with Blood Poisoning in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, W; Gong, J; Guo, Q; Huang, W; Li, J; Li, X; Li, Y; Lin, Y; Lou, A; Meng, Y; Qiu, H; Sun, J; Wang, G; Wang, J; Xu, Q | 1 |
| Alaaeldin, R; Attya, ME; Elhamadany, EY; Fathy, M; Mohyeldin, RH; Sharata, EE | 1 |
2 other study(ies) available for valsartan and Blood Poisoning
| Article | Year |
|---|---|
Sacubitril/valsartan alleviates sepsis-induced acute lung injury via inhibiting GSDMD-dependent macrophage pyroptosis in mice.
Topics: Acute Lung Injury; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Inflammasomes; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Sepsis; Valsartan | 2023 |
LCZ696 attenuates sepsis-induced liver dysfunction in rats; the role of oxidative stress, apoptosis, and JNK1/2-P38 signaling pathways.
Topics: Animals; Apoptosis; Caspase 3; Interleukin-6; Liver Diseases; Oxidative Stress; Rats; Sepsis; Signal Transduction; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Valsartan | 2023 |